Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Sep;68(3):501–506. doi: 10.1038/bjc.1993.376

Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.

M S Wilson 1, C M West 1, G D Wilson 1, S A Roberts 1, R D James 1, P F Schofield 1
PMCID: PMC1968401  PMID: 8353040

Abstract

Intra-tumoural heterogeneity of proliferation has been assessed by taking multiple biopsies from 30 colorectal cancers. Following in vivo IUDR labelling, dual parameter flow cytometry was used to measure tumour DNA index (DI) and labelling index (LI) and to derive DNA synthesis time (Ts) and potential doubling time (Tpot). Heterogeneity was seen for all parameters under investigation. Overall coefficients of variation (CV) and logarithmic transformation of Ts and Tpot (due to their non-gaussian distributions) indicate that LI (CV 25%) was the most variable parameter. Intra-tumoral heterogeneity in Tpot (lnTpot CV = 22%) was less than inter-individual variation (CV = 63%), suggesting that this variation should not be a limitation to the possible usefulness of this technique as an independent prognostic indicator. Correlations of Tpot values were examined between the shortest, the median and the value for a pooled homogenate sample from a single tumour. Using an homogenate, it was possible to accurately predict classification of tumour Tpot values as being below the median ('fast tumours') in 15 of 19 cases (79%). The data suggest that assaying an homogenate may allow a more rapid analysis of a multiply sampled tumour.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alama A., Merlo F., Chiara S., Muttini M. P., Guido T., Nicolò G., Conte P. F., Ragni N. Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma. Eur J Cancer. 1992;28A(6-7):1079–1080. doi: 10.1016/0959-8049(92)90461-a. [DOI] [PubMed] [Google Scholar]
  2. Begg A. C., Hofland I., Moonen L., Bartelink H., Schraub S., Bontemps P., Le Fur R., Van Den Bogaert W., Caspers R., Van Glabbeke M. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1449–1453. doi: 10.1016/0360-3016(90)90357-p. [DOI] [PubMed] [Google Scholar]
  3. Begg A. C., McNally N. J., Shrieve D. C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 1985 Nov;6(6):620–626. doi: 10.1002/cyto.990060618. [DOI] [PubMed] [Google Scholar]
  4. Begg A. C., Moonen L., Hofland I., Dessing M., Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol. 1988 Apr;11(4):337–347. doi: 10.1016/0167-8140(88)90205-8. [DOI] [PubMed] [Google Scholar]
  5. Bennett M. H., Wilson G. D., Dische S., Saunders M. I., Martindale C. A., Robinson B. M., O'Halloran A. E., Leslie M. D., Laing J. H. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer. 1992 Jun;65(6):870–878. doi: 10.1038/bjc.1992.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davidson S. E., West C. M., Hunter R. D. Lack of association between in vitro clonogenic growth of human cervical carcinoma and tumour stage, differentiation, patient age, host cell infiltration or patient survival. Int J Cancer. 1992 Jan 2;50(1):10–14. doi: 10.1002/ijc.2910500104. [DOI] [PubMed] [Google Scholar]
  7. Dexter D. L., Spremulli E. N., Fligiel Z., Barbosa J. A., Vogel R., VanVoorhees A., Calabresi P. Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med. 1981 Dec;71(6):949–956. doi: 10.1016/0002-9343(81)90312-0. [DOI] [PubMed] [Google Scholar]
  8. Dische S., Saunders M. I., Bennett M. H., Wilson G. D., McNally N. J. Cell proliferation and differentiation in squamous cancer. Radiother Oncol. 1989 May;15(1):19–23. doi: 10.1016/0167-8140(89)90114-x. [DOI] [PubMed] [Google Scholar]
  9. Dische S., Saunders M. I. Continuous, hyperfractionated, accelerated radiotherapy (CHART). Br J Cancer. 1989 Mar;59(3):325–326. doi: 10.1038/bjc.1989.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gold D. V., Shochat D., Primus F. J., Dexter D. L., Calabresi P., Goldenberg D. M. Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice. J Natl Cancer Inst. 1983 Jul;71(1):117–124. [PubMed] [Google Scholar]
  11. Goslin R., O'Brien M. J., Steele G., Mayer R., Wilson R., Corson J. M., Zamcheck N. Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med. 1981 Aug;71(2):246–253. doi: 10.1016/0002-9343(81)90125-x. [DOI] [PubMed] [Google Scholar]
  12. Hiddemann W., Von Bassewitz D. B., Kleinemeier H. J., Schulte-Brochterbeck E., Hauss J., Lingemann B., Büchner T., Grundmann E. DNA stemline heterogeneity in colorectal cancer. Cancer. 1986 Jul 15;58(2):258–263. doi: 10.1002/1097-0142(19860715)58:2<258::aid-cncr2820580210>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  13. Hoshino T., Nagashima T., Murovic J., Levin E. M., Levin V. A., Rupp S. M. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry. 1985 Nov;6(6):627–632. doi: 10.1002/cyto.990060619. [DOI] [PubMed] [Google Scholar]
  14. Jones D. J., Moore M., Schofield P. F. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg. 1988 Jan;75(1):28–33. doi: 10.1002/bjs.1800750111. [DOI] [PubMed] [Google Scholar]
  15. Jones D. J., Zaloudik J., James R. D., Haboubi N., Moore M., Schofield P. F. Predicting local recurrence of carcinoma of the rectum after preoperative radiotherapy and surgery. Br J Surg. 1989 Nov;76(11):1172–1175. doi: 10.1002/bjs.1800761120. [DOI] [PubMed] [Google Scholar]
  16. Kimball P. M., Brattain M. G. Isolation of a cellular subpopulation from a human colonic carcinoma cell line. Cancer Res. 1980 May;40(5):1574–1579. [PubMed] [Google Scholar]
  17. Koha M., Caspersson T. O., Wikström B., Brismar B. Heterogeneity of DNA distribution pattern in colorectal carcinoma. A microspectrophotometric study of fine needle aspirates. Anal Quant Cytol Histol. 1990 Oct;12(5):348–351. [PubMed] [Google Scholar]
  18. Kouri M., Pyrhönen S., Mecklin J. P., Järvinen H., Laasonen A., Franssila K., Nordling S. The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer. 1990 Dec;62(6):976–981. doi: 10.1038/bjc.1990.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Laurie J. A., Moertel C. G., Fleming T. R., Wieand H. S., Leigh J. E., Rubin J., McCormack G. W., Gerstner J. B., Krook J. E., Malliard J. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989 Oct;7(10):1447–1456. doi: 10.1200/JCO.1989.7.10.1447. [DOI] [PubMed] [Google Scholar]
  20. Leibovitz A., Stinson J. C., McCombs W. B., 3rd, McCoy C. E., Mazur K. C., Mabry N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976 Dec;36(12):4562–4569. [PubMed] [Google Scholar]
  21. Lindmark G., Glimelius B., Påhlman L., Enblad P. Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas. Int J Colorectal Dis. 1991 May;6(2):115–120. doi: 10.1007/BF00300207. [DOI] [PubMed] [Google Scholar]
  22. Metzger U. Adjuvant therapy for colorectal carcinoma. World J Surg. 1991 Sep-Oct;15(5):576–582. doi: 10.1007/BF01789201. [DOI] [PubMed] [Google Scholar]
  23. O'Brien M. J., Zamcheck N., Burke B., Kirkham S. E., Saravis C. A., Gottlieb L. S. Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Assessment of diagnostic value. Am J Clin Pathol. 1981 Mar;75(3):283–290. doi: 10.1093/ajcp/75.3.283. [DOI] [PubMed] [Google Scholar]
  24. Quirke P., Dixon M. F., Clayden A. D., Durdey P., Dyson J. E., Williams N. S., Bird C. C. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol. 1987 Apr;151(4):285–291. doi: 10.1002/path.1711510408. [DOI] [PubMed] [Google Scholar]
  25. Rew D. A., Campbell I. D., Taylor I., Wilson G. D. Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours. Br J Surg. 1992 Apr;79(4):335–339. doi: 10.1002/bjs.1800790418. [DOI] [PubMed] [Google Scholar]
  26. Rew D. A., Wilson G. D., Taylor I., Weaver P. C. Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg. 1991 Jan;78(1):60–66. doi: 10.1002/bjs.1800780120. [DOI] [PubMed] [Google Scholar]
  27. Riccardi A., Giordano M., Danova M., Girino M., Brugnatelli S., Ucci G., Mazzini G. Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia. Eur J Cancer. 1991;27(7):882–887. doi: 10.1016/0277-5379(91)90139-5. [DOI] [PubMed] [Google Scholar]
  28. Rognum T. O., Thorud E., Elgjo K., Brandtzaeg P., Orjasaeter H., Nygaard K. Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma. Br J Cancer. 1982 Jun;45(6):921–934. doi: 10.1038/bjc.1982.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Scott N. A., Grande J. P., Weiland L. H., Pemberton J. H., Beart R. W., Jr, Lieber M. M. Flow cytometric DNA patterns from colorectal cancers--how reproducible are they? Mayo Clin Proc. 1987 May;62(5):331–337. doi: 10.1016/s0025-6196(12)65435-4. [DOI] [PubMed] [Google Scholar]
  30. Shepherd N. A., Richman P. I., England J. Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol. 1988 Jul;155(3):213–219. doi: 10.1002/path.1711550306. [DOI] [PubMed] [Google Scholar]
  31. Sirachý J. An approach to the problem of heterogeneity of human tumour-cell populations. Br J Cancer. 1979 May;39(5):570–577. doi: 10.1038/bjc.1979.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tropé C., Håkansson L., Dencker H. Heterogeneity of human adenocarcinomas of the colon and the stomach as regards sensitivity to cytostatic drugs. Neoplasma. 1975;22(4):423–429. [PubMed] [Google Scholar]
  33. Wersto R. P., Liblit R. L., Deitch D., Koss L. G. Variability in DNA measurements in multiple tumor samples of human colonic carcinoma. Cancer. 1991 Jan 1;67(1):106–115. doi: 10.1002/1097-0142(19910101)67:1<106::aid-cncr2820670120>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  34. Wilson G. D. Assessment of human tumour proliferation using bromodeoxyuridine--current status. Acta Oncol. 1991;30(8):903–910. doi: 10.3109/02841869109088242. [DOI] [PubMed] [Google Scholar]
  35. Wilson G. D., McNally N. J., Dische S., Saunders M. I., Des Rochers C., Lewis A. A., Bennett M. H. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer. 1988 Oct;58(4):423–431. doi: 10.1038/bjc.1988.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wilson G. D., McNally N. J., Dunphy E., Kärcher H., Pfragner R. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry. 1985 Nov;6(6):641–647. doi: 10.1002/cyto.990060621. [DOI] [PubMed] [Google Scholar]
  37. Wilson M. S., West C. M., Wilson G. D., Roberts S. A., James R. D., Schofield P. F. An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br J Cancer. 1993 Apr;67(4):754–759. doi: 10.1038/bjc.1993.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zamcheck N., Doos W. G., Prudente R., Lurie B. B., Gottlieb L. S. Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology. Hum Pathol. 1975 Jan;6(1):31–45. doi: 10.1016/s0046-8177(75)80108-0. [DOI] [PubMed] [Google Scholar]
  39. van Oostrum I. E., Rozemuller E., Knol R. F., Erkens-Schulze S., Rutgers D. H. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods. Cell Tissue Kinet. 1990 Nov;23(6):523–544. doi: 10.1111/j.1365-2184.1990.tb01344.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES